I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Optimum Communications has struck $500 million of equity deals to provide the telecom operator with financial flexibility as it aims to address near-term maturities and whittle down its $26 billion ...

Optimum Communications Inc., formerly known as Altice USA, is negotiating a new financing deal that could dilute the collateral backing its existing debt, potentially escalating a feud with a group of ...

WASHINGTON, March 26 (Reuters) - Apollo Capital Management, BlackRock Financial Management and six other major asset managers have denied pressuring law firm Kirkland & Ellis to drop Optimum ...

The investment “significantly enhances” Infosys’ presence among providers, the announcement said, through the addition of new clients and expansion of technological capabilities. (Yutthana ...

Mangione, accused CEO killer, withdraws mental health defense plans for now Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. You might not be destined for a cubicle after all. As a number of big-name companies increase their ...

With spring training around the corner, MLB Network no longer is being carried on Optimum TV. Optimum dropped MLB Network on Jan. 31 as the two sides were unable to come to terms on a new carriage ...

Kirkland & Ellis is withdrawing as counsel to Optimum Communications after the telecom company filed an antitrust lawsuit against lenders that are also among the law firm’s clientele in the ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor inhibition where conventional immunotherapy fails. (Nanowerk Spotlight) ...